Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-02-27

AUTHORS

Yuko Matsui, Atsushi Suzuki, Tsuyoshi Shiga, Kotaro Arai, Nobuhisa Hagiwara

ABSTRACT

ObjectiveAtrial tachyarrhythmias (ATAs) lead to clinical deterioration and worsening heart failure (HF) in patients with acute decompensated HF (ADHF). We evaluated the effects of the ultrashort-acting intravenous β1-blocker landiolol on the heart rate, hemodynamics, and outcome in patients with ATAs and ADHF.MethodsA total of 67 consecutive hospitalized patients with ATAs and ADHF who were treated with landiolol (36 males, 67 ± 12 years) were included in this single-center retrospective study. The primary endpoints were changes in heart rate and systolic blood pressure from baseline during intravenous landiolol administration. The secondary endpoints included restoration of sinus rhythm and outcomes.ResultsThe median maintenance dose of intravenous landiolol was 3.0 (range 1.0–12.0) μg/kg/min and the median treatment duration was 5 (range 1–24) days. Intravenous landiolol reduced heart rate (141 ± 17 beats/min at baseline to 99 ± 20 beats/min at 6 h, P < 0.001) without a marked reduction in blood pressure or deterioration of HF. During landiolol treatment, 15 (22%) patients had spontaneously restored sinus rhythm. Eight patients experienced in-hospital death, and 41 (69%) were discharged with sinus rhythm. During the follow-up of 16 ± 12 months, patients with sinus rhythm showed a lower frequency of rehospitalization due to worsening HF than patients with ATAs (5/41 vs. 7/18, P = 0.019).ConclusionsOur results showed that intravenous landiolol reduces the heart rate without markedly decreasing blood pressure in patients with ATAs and ADHF. Approximately 70% of the discharged patients were in sinus rhythm, and these patients showed a lower frequency of rehospitalization due to worsening HF (UMIN-CTR no. UMIN000033650). More... »

PAGES

19-26

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1

DOI

http://dx.doi.org/10.1007/s40801-019-0149-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112400550

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30810944


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsui", 
        "givenName": "Yuko", 
        "id": "sg:person.010405336441.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010405336441.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Atsushi", 
        "id": "sg:person.01021613072.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021613072.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shiga", 
        "givenName": "Tsuyoshi", 
        "id": "sg:person.01273642053.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273642053.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arai", 
        "givenName": "Kotaro", 
        "id": "sg:person.01315321616.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315321616.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hagiwara", 
        "givenName": "Nobuhisa", 
        "id": "sg:person.01204734316.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204734316.73"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s40265-018-0883-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101176136", 
          "https://doi.org/10.1007/s40265-018-0883-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40256-018-0276-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103175695", 
          "https://doi.org/10.1007/s40256-018-0276-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40265-013-0077-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030203642", 
          "https://doi.org/10.1007/s40265-013-0077-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03016588", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029531145", 
          "https://doi.org/10.1007/bf03016588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-013-0377-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020627110", 
          "https://doi.org/10.1007/s00380-013-0377-3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02-27", 
    "datePublishedReg": "2019-02-27", 
    "description": "ObjectiveAtrial tachyarrhythmias (ATAs) lead to clinical deterioration and worsening heart failure (HF) in patients with acute decompensated HF (ADHF). We evaluated the effects of the ultrashort-acting intravenous \u03b21-blocker landiolol on the heart rate, hemodynamics, and outcome in patients with ATAs and ADHF.MethodsA total of 67 consecutive hospitalized patients with ATAs and ADHF who were treated with landiolol (36 males, 67\u2009\u00b1\u200912\u00a0years) were included in this single-center retrospective study. The primary endpoints were changes in heart rate and systolic blood pressure from baseline during intravenous landiolol administration. The secondary endpoints included restoration of sinus rhythm and outcomes.ResultsThe median maintenance dose of intravenous landiolol was 3.0 (range 1.0\u201312.0) \u03bcg/kg/min and the median treatment duration was 5 (range 1\u201324) days. Intravenous landiolol reduced heart rate (141\u2009\u00b1\u200917 beats/min at baseline to 99\u2009\u00b1\u200920 beats/min at 6\u00a0h, P\u2009<\u20090.001) without a marked reduction in blood pressure or deterioration of HF. During landiolol treatment, 15 (22%) patients had spontaneously restored sinus rhythm. Eight patients experienced in-hospital death, and 41 (69%) were discharged with sinus rhythm. During the follow-up of 16\u2009\u00b1\u200912\u00a0months, patients with sinus rhythm showed a lower frequency of rehospitalization due to worsening HF than patients with ATAs (5/41 vs. 7/18, P\u2009=\u20090.019).ConclusionsOur results showed that intravenous landiolol reduces the heart rate without markedly decreasing blood pressure in patients with ATAs and ADHF. Approximately 70% of the discharged patients were in sinus rhythm, and these patients showed a lower frequency of rehospitalization due to worsening HF (UMIN-CTR no. UMIN000033650).", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40801-019-0149-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1051855", 
        "issn": [
          "2199-1154", 
          "2198-9788"
        ], 
        "name": "Drugs - Real World Outcomes", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "acute decompensated HF", 
      "acute decompensated heart failure", 
      "decompensated heart failure", 
      "heart failure", 
      "sinus rhythm", 
      "intravenous landiolol", 
      "heart rate", 
      "blood pressure", 
      "single-center retrospective study", 
      "single-center experience", 
      "median maintenance dose", 
      "median treatment duration", 
      "systolic blood pressure", 
      "reduced heart rate", 
      "landiolol administration", 
      "landiolol treatment", 
      "clinical deterioration", 
      "primary endpoint", 
      "Secondary endpoints", 
      "maintenance dose", 
      "hospital death", 
      "retrospective study", 
      "atrial tachyarrhythmias", 
      "landiolol", 
      "treatment duration", 
      "patients", 
      "marked reduction", 
      "ConclusionsOur results", 
      "rehospitalization", 
      "rhythm", 
      "endpoints", 
      "outcomes", 
      "low frequency", 
      "failure", 
      "tachyarrhythmias", 
      "hemodynamics", 
      "deterioration", 
      "administration", 
      "dose", 
      "baseline", 
      "months", 
      "rate", 
      "death", 
      "treatment", 
      "total", 
      "pressure", 
      "duration", 
      "days", 
      "effect", 
      "min", 
      "frequency", 
      "restoration", 
      "study", 
      "reduction", 
      "experience", 
      "changes", 
      "lead", 
      "results", 
      "ATAs", 
      "ObjectiveAtrial tachyarrhythmias (ATAs) lead", 
      "tachyarrhythmias (ATAs) lead", 
      "ultrashort-acting intravenous \u03b21-blocker landiolol", 
      "intravenous \u03b21-blocker landiolol", 
      "\u03b21-blocker landiolol", 
      "intravenous landiolol administration", 
      "Intravenous landiolol reduced heart rate", 
      "landiolol reduced heart rate", 
      "deterioration of HF"
    ], 
    "name": "Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience", 
    "pagination": "19-26", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112400550"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40801-019-0149-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30810944"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40801-019-0149-1", 
      "https://app.dimensions.ai/details/publication/pub.1112400550"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_831.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40801-019-0149-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1'


 

This table displays all metadata directly associated to this object as RDF triples.

178 TRIPLES      22 PREDICATES      99 URIs      86 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40801-019-0149-1 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nfbeb9b68ab184555b5e05cfd04a305ed
4 schema:citation sg:pub.10.1007/bf03016588
5 sg:pub.10.1007/s00380-013-0377-3
6 sg:pub.10.1007/s40256-018-0276-1
7 sg:pub.10.1007/s40265-013-0077-4
8 sg:pub.10.1007/s40265-018-0883-9
9 schema:datePublished 2019-02-27
10 schema:datePublishedReg 2019-02-27
11 schema:description ObjectiveAtrial tachyarrhythmias (ATAs) lead to clinical deterioration and worsening heart failure (HF) in patients with acute decompensated HF (ADHF). We evaluated the effects of the ultrashort-acting intravenous β1-blocker landiolol on the heart rate, hemodynamics, and outcome in patients with ATAs and ADHF.MethodsA total of 67 consecutive hospitalized patients with ATAs and ADHF who were treated with landiolol (36 males, 67 ± 12 years) were included in this single-center retrospective study. The primary endpoints were changes in heart rate and systolic blood pressure from baseline during intravenous landiolol administration. The secondary endpoints included restoration of sinus rhythm and outcomes.ResultsThe median maintenance dose of intravenous landiolol was 3.0 (range 1.0–12.0) μg/kg/min and the median treatment duration was 5 (range 1–24) days. Intravenous landiolol reduced heart rate (141 ± 17 beats/min at baseline to 99 ± 20 beats/min at 6 h, P < 0.001) without a marked reduction in blood pressure or deterioration of HF. During landiolol treatment, 15 (22%) patients had spontaneously restored sinus rhythm. Eight patients experienced in-hospital death, and 41 (69%) were discharged with sinus rhythm. During the follow-up of 16 ± 12 months, patients with sinus rhythm showed a lower frequency of rehospitalization due to worsening HF than patients with ATAs (5/41 vs. 7/18, P = 0.019).ConclusionsOur results showed that intravenous landiolol reduces the heart rate without markedly decreasing blood pressure in patients with ATAs and ADHF. Approximately 70% of the discharged patients were in sinus rhythm, and these patients showed a lower frequency of rehospitalization due to worsening HF (UMIN-CTR no. UMIN000033650).
12 schema:genre article
13 schema:inLanguage en
14 schema:isAccessibleForFree true
15 schema:isPartOf Nb0f7d713c58d4cc59ff5c0a6f06e3215
16 Nc33e942c4115470db4695aa2f44cc357
17 sg:journal.1051855
18 schema:keywords ATAs
19 ConclusionsOur results
20 Intravenous landiolol reduced heart rate
21 ObjectiveAtrial tachyarrhythmias (ATAs) lead
22 Secondary endpoints
23 acute decompensated HF
24 acute decompensated heart failure
25 administration
26 atrial tachyarrhythmias
27 baseline
28 blood pressure
29 changes
30 clinical deterioration
31 days
32 death
33 decompensated heart failure
34 deterioration
35 deterioration of HF
36 dose
37 duration
38 effect
39 endpoints
40 experience
41 failure
42 frequency
43 heart failure
44 heart rate
45 hemodynamics
46 hospital death
47 intravenous landiolol
48 intravenous landiolol administration
49 intravenous β1-blocker landiolol
50 landiolol
51 landiolol administration
52 landiolol reduced heart rate
53 landiolol treatment
54 lead
55 low frequency
56 maintenance dose
57 marked reduction
58 median maintenance dose
59 median treatment duration
60 min
61 months
62 outcomes
63 patients
64 pressure
65 primary endpoint
66 rate
67 reduced heart rate
68 reduction
69 rehospitalization
70 restoration
71 results
72 retrospective study
73 rhythm
74 single-center experience
75 single-center retrospective study
76 sinus rhythm
77 study
78 systolic blood pressure
79 tachyarrhythmias
80 tachyarrhythmias (ATAs) lead
81 total
82 treatment
83 treatment duration
84 ultrashort-acting intravenous β1-blocker landiolol
85 β1-blocker landiolol
86 schema:name Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience
87 schema:pagination 19-26
88 schema:productId N97e6fc8db8a14173858b9249f6fa8362
89 Nbf38d09f59454dad8e855e6bf371aca1
90 Nf3609b99d1e24174922cb7aa8a6afad4
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112400550
92 https://doi.org/10.1007/s40801-019-0149-1
93 schema:sdDatePublished 2021-11-01T18:37
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N8c15afcf82e344dc8e418f739ffdbeb5
96 schema:url https://doi.org/10.1007/s40801-019-0149-1
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N8c15afcf82e344dc8e418f739ffdbeb5 schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 N97e6fc8db8a14173858b9249f6fa8362 schema:name dimensions_id
103 schema:value pub.1112400550
104 rdf:type schema:PropertyValue
105 Na412194813fe4bc9b9c2f44f39213876 rdf:first sg:person.01273642053.33
106 rdf:rest Nd2569b06c7e14a569f268e8b4de1a4a9
107 Nb0f7d713c58d4cc59ff5c0a6f06e3215 schema:volumeNumber 6
108 rdf:type schema:PublicationVolume
109 Nb6550e1a7669470b9e7c6e7d0727e389 rdf:first sg:person.01021613072.27
110 rdf:rest Na412194813fe4bc9b9c2f44f39213876
111 Nbf38d09f59454dad8e855e6bf371aca1 schema:name doi
112 schema:value 10.1007/s40801-019-0149-1
113 rdf:type schema:PropertyValue
114 Nc33e942c4115470db4695aa2f44cc357 schema:issueNumber 1
115 rdf:type schema:PublicationIssue
116 Nd2569b06c7e14a569f268e8b4de1a4a9 rdf:first sg:person.01315321616.31
117 rdf:rest Nf85f9acdd62f499eb8c848a76a7e46bf
118 Nf3609b99d1e24174922cb7aa8a6afad4 schema:name pubmed_id
119 schema:value 30810944
120 rdf:type schema:PropertyValue
121 Nf85f9acdd62f499eb8c848a76a7e46bf rdf:first sg:person.01204734316.73
122 rdf:rest rdf:nil
123 Nfbeb9b68ab184555b5e05cfd04a305ed rdf:first sg:person.010405336441.72
124 rdf:rest Nb6550e1a7669470b9e7c6e7d0727e389
125 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
126 schema:name Medical and Health Sciences
127 rdf:type schema:DefinedTerm
128 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
129 schema:name Cardiorespiratory Medicine and Haematology
130 rdf:type schema:DefinedTerm
131 sg:journal.1051855 schema:issn 2198-9788
132 2199-1154
133 schema:name Drugs - Real World Outcomes
134 schema:publisher Springer Nature
135 rdf:type schema:Periodical
136 sg:person.01021613072.27 schema:affiliation grid-institutes:grid.410818.4
137 schema:familyName Suzuki
138 schema:givenName Atsushi
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021613072.27
140 rdf:type schema:Person
141 sg:person.010405336441.72 schema:affiliation grid-institutes:grid.410818.4
142 schema:familyName Matsui
143 schema:givenName Yuko
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010405336441.72
145 rdf:type schema:Person
146 sg:person.01204734316.73 schema:affiliation grid-institutes:grid.410818.4
147 schema:familyName Hagiwara
148 schema:givenName Nobuhisa
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204734316.73
150 rdf:type schema:Person
151 sg:person.01273642053.33 schema:affiliation grid-institutes:grid.410818.4
152 schema:familyName Shiga
153 schema:givenName Tsuyoshi
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273642053.33
155 rdf:type schema:Person
156 sg:person.01315321616.31 schema:affiliation grid-institutes:grid.410818.4
157 schema:familyName Arai
158 schema:givenName Kotaro
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315321616.31
160 rdf:type schema:Person
161 sg:pub.10.1007/bf03016588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029531145
162 https://doi.org/10.1007/bf03016588
163 rdf:type schema:CreativeWork
164 sg:pub.10.1007/s00380-013-0377-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020627110
165 https://doi.org/10.1007/s00380-013-0377-3
166 rdf:type schema:CreativeWork
167 sg:pub.10.1007/s40256-018-0276-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103175695
168 https://doi.org/10.1007/s40256-018-0276-1
169 rdf:type schema:CreativeWork
170 sg:pub.10.1007/s40265-013-0077-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030203642
171 https://doi.org/10.1007/s40265-013-0077-4
172 rdf:type schema:CreativeWork
173 sg:pub.10.1007/s40265-018-0883-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101176136
174 https://doi.org/10.1007/s40265-018-0883-9
175 rdf:type schema:CreativeWork
176 grid-institutes:grid.410818.4 schema:alternateName Department of Cardiology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan
177 schema:name Department of Cardiology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan
178 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...